1. Home
  2. PMTS vs AGEN Comparison

PMTS vs AGEN Comparison

Compare PMTS & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPI Card Group Inc.

PMTS

CPI Card Group Inc.

HOLD

Current Price

$28.24

Market Cap

332.4M

Sector

Finance

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

N/A

Current Price

$8.24

Market Cap

274.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PMTS
AGEN
Founded
2007
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.4M
274.8M
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
PMTS
AGEN
Price
$28.24
$8.24
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$27.67
$14.50
AVG Volume (30 Days)
112.9K
1.1M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
100.00
EPS
0.34
0.96
Revenue
$312,189,000.00
$42,877,086.00
Revenue This Year
$9.95
$107.63
Revenue Next Year
$10.02
N/A
P/E Ratio
$83.46
$8.43
Revenue Growth
12.27
89.95
52 Week Low
$10.81
$2.71
52 Week High
$31.25
$8.85

Technical Indicators

Market Signals
Indicator
PMTS
AGEN
Relative Strength Index (RSI) 60.69 59.43
Support Level $27.00 $2.97
Resistance Level $31.25 $8.70
Average True Range (ATR) 1.04 0.57
MACD -0.30 -0.08
Stochastic Oscillator 55.25 63.66

Price Performance

Historical Comparison
PMTS
AGEN

About PMTS CPI Card Group Inc.

CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit segment, which principally produce secure debit and credit cards and provide card services for U.S. card-issuing financial institutions, including personalization, instant issuance and other payment solutions such as digital push provisioning for mobile wallets; Prepaid Debit, which provides secure packaging solutions, Prepaid Debit Cards, and other integrated prepaid card services to prepaid program managers in the U.S.; and other: principally corporate expenses. The firm generates key revenue from Debit and Credit segment.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: